Publications by authors named "Roger-Axel Greiner"

Claim this Profile
P
Prevalence of and Factors Associated With the Prescription of Fibrates Among Patients Receiving Lipid-Lowering Drugs in Germany.
Louis Jacob, Roger-Axel Greiner, Mark Luedde, Karel Kostev

J Cardiovasc Pharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany.
Jan Steffen Jürgensen, Robert Ikenberg, Roger-Axel Greiner, Volker Hösel

Eur J Health Econ· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of ticagrelor and generic clopidogrel in patients with acute coronary syndrome in Switzerland.
David Gasche, Tanja Ulle, Bernhard Meier, Roger-Axel Greiner

Swiss Med Wkly· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of posaconazole compared with standard azole therapy for prevention of invasive fungal infections in patients at high risk in Switzerland.
Roger-Axel Greiner, Yvonne Meier, George Papadopoulos, Amy K O'Sullivan, Alexander Imhof

Oncology· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of biologics for moderate-to-severe psoriasis from the perspective of the Swiss healthcare system.
Roger-Axel GREINER, Lasse R Braathen

Eur J Dermatol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness and cost utility of risedronate for osteoporosis treatment and fracture prevention in women: a Swiss perspective.
Jean-Blaise Wasserfallen, Marc-Antoine Krieg, Roger-Axel Greiner, Olivier Lamy

J Med Econ· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis